ClinicalTrials.gg
RecruitingNCT07625969Updated Jul 7, 2026

Using Single and Combined Nudge Strategies to Promote Healthier Beverage Intake Among College Students

An interventional study of choice architecture and choice architecture in Obesity and Food Selection, sponsored by Nanjing Medical University. Recruiting at 1 site in China. Per ClinicalTrials.gov, last updated 2026-07-07.

Sponsored by Nanjing Medical University · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Primary completion was expected by Jul 2026, 3 months ago, but the record still lists the study as recruiting.
  • Started Jul 2026; still recruiting 4 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
1,000
Allocation
Randomized
Sex
All
01

Study summary

The primary objective of this study was to examine whether three nudging strategies influence beverage consumption behavior among Chinese university students. These interventions included health warning messages, hedonic labeling, and a combination of health warning and hedonic labeling. A between-subjects experimental design with a single factor was employed to assess the effects of these strategies on students' choices between sugar-sweetened and sugar-free beverages, thereby evaluating their effectiveness in promoting healthier beverage selections.

Read the detailed description

As the prevalence of overweight, obesity, and chronic diseases continues to escalate, excessive consumption of sugar-sweetened beverages (SSBs) has emerged as a growing public health concern globally. One approach to reducing beverage intake while conserving resources is the utilization of nudge strategies. Nudge strategies, characterized by their low cost and ease of implementation, facilitate individuals in making more accurate and beneficial choices in a predictable manner, through subtle interventions that do not prohibit any options or significantly alter incentives. This study will be conducted in a classroom setting, where participants will be randomly assigned to one of four groups: a no-nudge control group, a health warning group, a hedonic labeling group, and a combined health warning plus hedonic labeling group.

02

Conditions studied

  • Obesity
  • Food Selection
03

In context

Obesity

11,522 studies on the registry are indexed under Obesity; 2,033 are open to participants now.

This study's planned enrollment of 1,000 is above the median of 67 across 9,006 interventional studies indexed under Obesity.

Browse Obesity studies →

Lead sponsor

Nanjing Medical University is the lead sponsor of 171 studies on the registry; 52 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • college students
  • willing to participate

Exclusion criteria

Exclusion Criteria:

none

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
1,000 participants (estimated)

Study arms

  • No intervention
    Control

    In this group, no nudge interventions were implemented, only data were collected.

  • Experimental
    choice architecture (health warning Information)

    The platform presented information outlining the potential health risks associated with excessive consumption of sugar-sweetened beverages.

    Behavioral: choice architecture

  • Experimental
    choice architecture (hedonic label Information)

    Students are exposed to hedonic information about sugar-free beverages on the Wenjuanxing platform to "nudge" students towards healthier choices

    Behavioral: choice architecture

  • Experimental
    choice architecture (hedonic label Information+health warning Information)

    Students receive both health-risk messages about sugary drinks and hedonic information about sugar-free beverages on the Wenjuanxing platform, combining two nudging strategies to promote healthier choices.

    Behavioral: choice architecture

Interventions

  • Behavioralchoice architecture

    Showing the various harms that can come from long-term excessive consumption of sugary beverages on the platform.

  • Behavioralchoice architecture

    The platform shows the hedonic information about sugar-free beverages.

  • Behavioralchoice architecture

    The platform shows both hedonic information about sugar-free beverages and information on the various harms of long-term excessive sugary beverage consumption.

06

What researchers measure

Primary outcomes

  1. The proportion (or likelihood) of selecting sugar-free beverages

    The probability of choosing a sugar-free beverage (binary outcome: sugar-sweetened = 0, sugar-free = 1) across five menu-selection tasks.

    Time frame: day 1

Secondary outcomes

  1. Participants' Perceived Intrusiveness of Nudges

    A 5-point Likert scale (1 = strongly disagree, 5 = strongly agree) was employed. Higher scores indicate greater perceived intrusiveness.

    Time frame: day 1

  2. Participants' Support for Nudges

    A 5-point Likert scale (1 = strongly disagree, 5 = strongly agree) was employed. Higher scores indicate greater support for the nudging strategy

    Time frame: day 1

  3. Participants' Perceived effectiveness of Nudges

    A 5-point Likert scale (1 = strongly disagree, 5 = strongly agree) was employed. Higher scores indicate greater perceived effectiveness.

    Time frame: day 1

07

Study locations

1 of 1 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jul 2026 (actual). Primary completion is estimated for Jul 2026, 0 months after the start.

Of 3,680 non-industry interventional studies with no phase under Obesity, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 43. This study's planned 0 months is below that.

Counting every sponsor, half of 3,843 studies reached it within 22 months; a quarter within 10 and three quarters within 42.

How these figures are worked out, and which studies are left out of them.

Registered
May 29, 2026
First posted
Jun 4, 2026
StartActual
Jul 2, 2026
Primary completionEst.
Jul 30, 2026
CompletionEst.
Jul 30, 2026
Last update
Jul 7, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 7, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07625969
Responsible party
Yuan He (Professor, Nanjing Medical University) — Principal investigator
First posted
Jun 4, 2026
Start date
Jul 2, 2026
Primary completion
Jul 30, 2026 (estimated)
Completion
Jul 30, 2026 (estimated)
Last update
Jul 7, 2026

Study contacts

Yuan He
Contact
heyuan@njmu.edu.cn
18651625286

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion